Skip to content

Medical-device intelligence

Hyland Therapeutic Div., Travenol Laboratories: FDA clearances and recalls

Research Hyland Therapeutic Div., Travenol Laboratories in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

44 clearance records and 0 recall records in the covered releases, across 1 source company names and 36 product codes. Dated history runs from Oct 29, 1976 to Apr 26, 1982.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

44 matching records
Device / recordCompany in FDA recordSourceSource date
ALUMINA SILICA-ACTIVATED PARTIAL THROMK820835 · GFOHyland Therapeutic Div., Travenol Laboratories510(k)Apr 26, 1982FDA decision date
HAEMOPHILUS INFLUENZAE TYPE B ANTISERUMK820192 · GRPHyland Therapeutic Div., Travenol Laboratories510(k)Mar 11, 1982FDA decision date
NEPHELOMETRIC SOLID TURBIDITY STANDARDK812220 · JIWHyland Therapeutic Div., Travenol Laboratories510(k)Aug 18, 1981FDA decision date
Q-PAK THERAPEUTIC DRUG MONIT. CONTROL SK810078 · DIFHyland Therapeutic Div., Travenol Laboratories510(k)Feb 2, 1981FDA decision date
OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.K810077 · DIFHyland Therapeutic Div., Travenol Laboratories510(k)Jan 28, 1981FDA decision date
ALERT A,HDL-APOLIPOROTEIN A, TEST KITK802610 · DERHyland Therapeutic Div., Travenol Laboratories510(k)Jan 5, 1981FDA decision date
LOW IONIC STRENGTH SOLUTION (LISS)K791113 · KSGHyland Therapeutic Div., Travenol Laboratories510(k)Jun 28, 1979FDA decision date
TEST CELLSK790249 · KSFHyland Therapeutic Div., Travenol Laboratories510(k)May 16, 1979FDA decision date
GLOBULIN TEST, HUMAN THYROXINE BINDINGK781225 · CEEHyland Therapeutic Div., Travenol Laboratories510(k)Aug 31, 1978FDA decision date
AUTOMATED ENZYMEK780962 · KSKHyland Therapeutic Div., Travenol Laboratories510(k)Jul 27, 1978FDA decision date
DILUTOR TRANSPORTERK780785 · JQWHyland Therapeutic Div., Travenol Laboratories510(k)Jun 14, 1978FDA decision date
LAS-R HUMAN IGE TESTK780753 · DGCHyland Therapeutic Div., Travenol Laboratories510(k)Jun 6, 1978FDA decision date
LAS-R HUMAN COMPLEMENT CLQ TESTK780729 · DAKHyland Therapeutic Div., Travenol Laboratories510(k)May 18, 1978FDA decision date
THROMBOPLASTIN DRIEDK780203 · GJSHyland Therapeutic Div., Travenol Laboratories510(k)Mar 27, 1978FDA decision date
LAS-R HUMAN C1 ESTERASE INHIBITOR TESTK780335 · DBAHyland Therapeutic Div., Travenol Laboratories510(k)Mar 22, 1978FDA decision date
CHEMISTRY CONTROL & REFERENCE SERUMSK780204 · JJTHyland Therapeutic Div., Travenol Laboratories510(k)Mar 3, 1978FDA decision date
LAS-R HUMAN IGD TESTK772327 · CZJHyland Therapeutic Div., Travenol Laboratories510(k)Feb 28, 1978FDA decision date
LAS-R HUMAN ANTITHROMBIN III TESTK772328 · JBQHyland Therapeutic Div., Travenol Laboratories510(k)Feb 3, 1978FDA decision date
LAS-R HUMAN PREALBUMIN TESTK772329 · JZJHyland Therapeutic Div., Travenol Laboratories510(k)Feb 3, 1978FDA decision date
LAS-R HUMAN C3 PROACTIVATOR TESTK772084 · JZHHyland Therapeutic Div., Travenol Laboratories510(k)Jan 24, 1978FDA decision date
LAS-R HUMAN PLASMINOGEN TESTK772085 · DDXHyland Therapeutic Div., Travenol Laboratories510(k)Jan 24, 1978FDA decision date
HERPES I.D. TM TESTK771445 · GQLHyland Therapeutic Div., Travenol Laboratories510(k)Dec 14, 1977FDA decision date
LAS-R CERULOPLASMIN TESTK771795 · DDBHyland Therapeutic Div., Travenol Laboratories510(k)Nov 14, 1977FDA decision date
TMA BICARBONATE/GLYCEROL DILUENTK771700Hyland Therapeutic Div., Travenol Laboratories510(k)Nov 11, 1977FDA decision date
GLYCOPROTEIN TEST, LAS-R HUMAN 1-ACIDK771879 · DENHyland Therapeutic Div., Travenol Laboratories510(k)Oct 19, 1977FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗